| Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme MC Arendrup, E Dzajic, RH Jensen, HK Johansen, P Kjaldgaard, ... Clinical Microbiology and Infection 19 (8), e343-e353, 2013 | 250 | 2013 |
| Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance KL Mortensen, RH Jensen, HK Johansen, M Skov, T Pressler, SJ Howard, ... Journal of clinical microbiology 49 (6), 2243-2251, 2011 | 198 | 2011 |
| Emergence of methicillin resistance predates the clinical use of antibiotics J Larsen, CL Raisen, X Ba, NJ Sadgrove, GF Padilla-González, ... Nature 602 (7895), 135-141, 2022 | 183 | 2022 |
| Estimating evaporation with thermal UAV data and two-source energy balance models H Hoffmann, H Nieto, R Jensen, R Guzinski, P Zarco-Tejada, T Friborg Hydrology and Earth System Sciences 20 (2), 697-713, 2016 | 174 | 2016 |
| Emerging Terbinafine Resistance in Trichophyton: Clinical Characteristics, Squalene Epoxidase Gene Mutations, and a Reliable EUCAST Method for Detection DML Saunte, RK Hare, KM Jørgensen, R Jørgensen, M Deleuran, ... Antimicrobial agents and chemotherapy 63 (10), 10.1128/aac. 01126-19, 2019 | 141 | 2019 |
| Crop water stress maps for an entire growing season from visible and thermal UAV imagery H Hoffmann, R Jensen, A Thomsen, H Nieto, J Rasmussen, T Friborg Biogeosciences 13 (24), 6545-6563, 2016 | 141 | 2016 |
| Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations MC Arendrup, DS Perlin, RH Jensen, SJ Howard, J Goodwin, W Hope Antimicrobial agents and chemotherapy 56 (5), 2435-2442, 2012 | 131 | 2012 |
| Update from a 12-year nationwide fungemia surveillance: increasing intrinsic and acquired resistance causes concern KMT Astvad, HK Johansen, BL Røder, FS Rosenvinge, JD Knudsen, ... Journal of Clinical Microbiology 56 (4), 10.1128/jcm. 01564-17, 2018 | 117 | 2018 |
| In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales Order MC Arendrup, RH Jensen, J Meletiadis Antimicrobial agents and chemotherapy 59 (12), 7735-7742, 2015 | 112 | 2015 |
| A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility KL Mortensen, HK Johansen, K Fuursted, JD Knudsen, B Gahrn-Hansen, ... European Journal of Clinical Microbiology & Infectious Diseases 30, 1355-1363, 2011 | 110 | 2011 |
| Molecular basis of antifungal drug resistance in yeasts F Morio, RH Jensen, P Le Pape, MC Arendrup International journal of antimicrobial agents 50 (5), 599-606, 2017 | 105 | 2017 |
| Molecular diagnosis of dermatophyte infections RH Jensen, MC Arendrup Current opinion in infectious diseases 25 (2), 126-134, 2012 | 105 | 2012 |
| Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations RH Jensen, KMT Astvad, LV Silva, D Sanglard, R Jørgensen, KF Nielsen, ... Journal of Antimicrobial Chemotherapy 70 (9), 2551-2555, 2015 | 99 | 2015 |
| First Detection of TR46/Y121F/T289A and TR34/L98H Alterations in Aspergillus fumigatus Isolates from Azole-Naive Patients in Denmark despite Negative … KMT Astvad, RH Jensen, TM Hassan, EG Mathiasen, GM Thomsen, ... Antimicrobial agents and chemotherapy 58 (9), 5096-5101, 2014 | 94 | 2014 |
| Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species RH Jensen, MC Arendrup Journal of clinical microbiology 49 (2), 549-556, 2011 | 87 | 2011 |
| Climate and site management as driving factors for the atmospheric greenhouse gas exchange of a restored wetland M Herbst, T Friborg, K Schelde, R Jensen, R Ringgaard, V Vasquez, ... Biogeosciences 10 (1), 39-52, 2013 | 81 | 2013 |
| Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment RH Jensen Dan Med J 63 (10), 1-34, 2016 | 74 | 2016 |
| Posttreatment antifungal resistance among colonizing Candida isolates in candidemia patients: results from a systematic multicenter study RH Jensen, HK Johansen, LM Søes, LE Lemming, FS Rosenvinge, ... Antimicrobial agents and chemotherapy 60 (3), 1500-1508, 2016 | 73 | 2016 |
| In Vivo Emergence of Aspergillus terreus with Reduced Azole Susceptibility and a Cyp51a M217I Alteration MC Arendrup, RH Jensen, K Grif, M Skov, T Pressler, HK Johansen, ... The Journal of infectious diseases 206 (6), 981-985, 2012 | 69 | 2012 |
| Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark F Hagen, R Hare Jensen, JF Meis, MC Arendrup Mycoses 59 (9), 576-584, 2016 | 60 | 2016 |
